On February 20, Barclays initiated coverage of Eli Lilly and Company (NYSE:LLY) with an Overweight rating. The firm set a $1,350 price target on the stock.
Eric J. Larson is a community pharmacist, multi-store pharmacy owner in the Orlando area, and president of the Florida ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results